Cargando…

Serum Fibroblast Growth Factor 21 Level Is Associated with Aortic Stiffness in Patients on Maintenance Hemodialysis

BACKGROUND: Fibroblast growth factor 21 (FGF-21) is a hormone that regulates glucose and lipid metabolism. High serum FGF-21 levels are associated with carotid atherosclerosis and coronary artery disease. This cross-sectional study aimed to assess the relationship between serum FGF-21 levels and car...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiu, Liang-Te, Hung, Chi-Di, Lin, Lin, Lin, Yu-Li, Hsu, Bang-Gee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856816/ https://www.ncbi.nlm.nih.gov/pubmed/35186330 http://dx.doi.org/10.1155/2022/7098458

Ejemplares similares

Serum P-Cresyl Sulfate Is a Predictor of Central Arterial Stiffness in Patients on Maintenance Hemodialysis
por: Lai, Yu-Hsien, et al.
Publicado: (2019)

Serum Levels of Fibroblast Growth Factor 21 Are Positively Associated with Aortic Stiffness in Patients with Type 2 Diabetes Mellitus
por: Huang, Sin-Yi, et al.
Publicado: (2021)

Lower Serum Fibroblast Growth Factor 21 Levels are Associated with Normal Lumbar Spine Bone Mineral Density in Hemodialysis Patients
por: Wu, Yin-Ting, et al.
Publicado: (2020)

Serum Malondialdehyde-Modified Low-Density Lipoprotein Is a Risk Factor for Central Arterial Stiffness in Maintenance Hemodialysis Patients
por: Hou, Jia-Sian, et al.
Publicado: (2020)

Serum Trimethylamine N-Oxide Level Is Positively Associated with Aortic Stiffness Measured by Carotid–Femoral Pulse Wave Velocity in Patients Undergoing Maintenance Hemodialysis
por: Huang, Po-Yu, et al.
Publicado: (2023)

High serum leptin levels are associated with central arterial stiffness in geriatric patients on hemodialysis
por: Kuo, Chiu-Huang, et al.
Publicado: (2018)

Serum resistin as an independent marker of aortic stiffness in patients with coronary artery disease
por: Wang, Ji-Hung, et al.
Publicado: (2017)

Hyperleptinemia positively associated with central arterial stiffness in hemodialysis patients
por: Kuo, Chiu-Huang, et al.
Publicado: (2018)

Serum Irisin Level Is Positively Associated with Bone Mineral Density in Patients on Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Negative Correlation of Serum Adiponectin Level with Aortic Stiffness in Elderly Diabetic Persons
por: Hung, Jui-Jung, et al.
Publicado: (2022)

Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis
por: Huang, Po-Yu, et al.
Publicado: (2023)

Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3–5
por: Lu, Jing-Wun, et al.
Publicado: (2020)

Association between Serum Soluble Urokinase-Type Plasminogen Activator Receptor Level and Arterial Stiffness in Chronic Hemodialysis Patients
por: Lin, Wei-Chen, et al.
Publicado: (2023)

Association of Low Serum l-Carnitine Levels with Aortic Stiffness in Patients with Non-Dialysis Chronic Kidney Disease
por: Hsieh, Yi-Jen, et al.
Publicado: (2020)

A Retrospective Cohort Study of the Association between Serum Osteopontin Levels and Aortic Stiffness in Hypertensive Patients
por: Chang, Yuan-Chieh, et al.
Publicado: (2022)

The serum sclerostin level is positively associated with the aortic augmentation index in patients on peritoneal dialysis
por: Lin, Lin, et al.
Publicado: (2019)

Serum Osteopontin Level Is Positively Associated with Aortic Stiffness in Patients with Peritoneal Dialysis
por: Chang, Kai-Hsiang, et al.
Publicado: (2022)

Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid–femoral pulse wave velocity in hemodialysis patients: a cross sectional study
por: Hou, Jia-Sian, et al.
Publicado: (2019)

Serum Osteoprotegerin Level Is Negatively Associated with Bone Mineral Density in Patients Undergoing Maintenance Hemodialysis
por: Lu, Chia-Wen, et al.
Publicado: (2021)

Serum Fetuin A and Chemerin Levels Correlate with Hepatic Steatosis and Regional Adiposity in Maintenance Hemodialysis Patients
por: Chen, Hung-Yuan, et al.
Publicado: (2012)

Age and Serum Adipocyte Fatty-Acid-Binding Protein Level Are Associated with Aortic Stiffness in Coronary Artery Bypass Graft Patients
por: Huang, Nai-Wei, et al.
Publicado: (2022)

Serum Fibroblast Growth Factor 21 Levels Are Positively Associated with Metabolic Syndrome in Patients with Type 2 Diabetes
por: Gao, Ruo-Yao, et al.
Publicado: (2019)

Resistin: A Potential Indicator of Aortic Stiffness in Non-Dialysis Chronic Kidney Disease Patients
por: Kuo, Chiu-Huang, et al.
Publicado: (2023)

Negative correlation of serum adiponectin level with peripheral artery occlusive disease in hemodialysis patients
por: Lai, Yu-Hsien, et al.
Publicado: (2019)

Association of Low Serum Adiponectin Levels with Aortic Arterial Stiffness in Patients with Type 2 Diabetes
por: Shih, Cian-Huei, et al.
Publicado: (2019)

Serum levels of sclerostin as a potential biomarker in central arterial stiffness among hypertensive patients
por: Chang, Yu-Chi, et al.
Publicado: (2018)

Serum Osteocalcin Level is Negatively Associated with Vascular Reactivity Index by Digital Thermal Monitoring in Kidney Transplant Recipients
por: Lin, Lin, et al.
Publicado: (2020)

Serum adipocyte fatty acid-binding protein level is positively associated with aortic stiffness in nondialysis chronic kidney disease patients: A cross-sectional study
por: Su, Hsiao-Yuan, et al.
Publicado: (2022)

Association of serum leptin levels with central arterial stiffness in coronary artery disease patients
por: Tsai, Jen-Pi, et al.
Publicado: (2016)

Elevated serum leptin levels are associated with low muscle strength and muscle quality in male patients undergoing chronic hemodialysis
por: Hsu, Bang-Gee, et al.
Publicado: (2020)

Fibroblast growth factor-23 levels in maintenance hemodialysis patients in India
por: Anandh, U., et al.
Publicado: (2017)

Increased Serum Leptin Level Predicts Bone Mineral Density in Hemodialysis Patients
por: Wang, Chih-Hsien, et al.
Publicado: (2020)

Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients
por: Wu, Chun-Feng, et al.
Publicado: (2020)

Metabolic Syndrome With Aortic Arterial Stiffness And First Hospitalization Or Mortality In Coronary Artery Disease Patients
por: Chen, Yen-Chih, et al.
Publicado: (2019)

Low serum adiponectin level is associated with metabolic syndrome and is an independent marker of peripheral arterial stiffness in hypertensive patients
por: Chen, Ming-Chun, et al.
Publicado: (2017)

Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis
por: MIAO, LI-YING, et al.
Publicado: (2014)

Correlation of serum levels of fibroblast growth factor 23 and Klotho protein levels with bone mineral density in maintenance hemodialysis patients
por: Zheng, Shubei, et al.
Publicado: (2018)

Association of SARC-F Questionnaire and Mortality in Prevalent Hemodialysis Patients
por: Lin, Yu-Li, et al.
Publicado: (2020)

Serum Angiopoietin-like Protein 3 Level Is Associated with Peripheral Arterial Stiffness in Patients with Coronary Artery Disease
por: Hsiao, Chien-Hao, et al.
Publicado: (2021)

Serum Malondialdehyde-Oxidized Low-Density Lipoprotein Level Is Associated with Arterial Stiffness by Cardio-Ankle Vascular Index in Coronary Artery Bypass Graft Patients
por: Hung, Ting, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ura7fg9hr86iqj39ekkmfbpb4o